Standardization of fluorescence in situ hybridization studies on chronic lymphocytic leukemia (CLL) blood and marrow cells by the CLL Research Consortium

Stephanie A. Smoley, Daniel L. Van Dyke, Neil E. Kay, Nyla A. Heerema, Marie L. Dell' Aquila, Paola Dal Cin, Prasad Koduru, Ayala Aviram, Laura Rassenti, John C. Byrd, Kanti R. Rai, Jennifer R. Brown, Andrew W. Greaves, Jeanette Eckel-Passow, Donna Neuberg, Thomas J. Kipps, Gordon W. Dewald

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Five laboratories in the Chronic Lymphocytic Leukemia (CLL) Research Consortium (CRC) investigated standardizing and pooling of fluorescence in situ hybridization (FISH) results as a collaborative research project. This investigation used fixed bone marrow and blood cells available from previous conventional cytogenetic or FISH studies in two pilot studies, a one-day workshop, and proficiency test. Multiple FISH probe strategies were used to detect 6q-, 11q-, +12, 13q-, 17p-, and IGH rearrangements. Ten specimens were studied by participants who used their own probes (pilot study 1). Of 312 FISH interpretations, 224 (72%) were true-negative, 74 (24%) true-positive, 6 (2%) false-negative, and 8 (3%) false-positive. In pilot study no. 2, each participant studied two specimens using identical FISH probe sets to control for variation due to probe sets and probe strategies. Of 80 FISH interpretations, no false interpretations were identified. At a subsequent workshop, discussions produced agreement on scoring criteria. The proficiency test that followed produced no false-negative results and 4% (3/68) false-positive interpretations. Interpretation disagreements among laboratories were primarily attributable to inadequate normal cutoffs, inconsistent scoring criteria, and the use of different FISH probe strategies. Collaborative organizations that use pooled FISH results may wish to impose more conservative empiric normal cutoff values or use an equivocal range between the normal cutoff and the abnormal reference range to eliminate false-positive interpretations. False-negative results will still occur, and would be expected in low-percentage positive cases; these would likely have less clinical significance than false positive results. Individual laboratories can help by closely following rigorous quality assurance guidelines to ensure accurate and consistent FISH studies in their clinical practice and research.

Original languageEnglish (US)
Pages (from-to)141-148
Number of pages8
JournalCancer Genetics and Cytogenetics
Volume203
Issue number2
DOIs
StatePublished - Dec 2010

Fingerprint

B-Cell Chronic Lymphocytic Leukemia
Fluorescence In Situ Hybridization
Blood Cells
Bone Marrow
Research
Reference Values
Education
Cytogenetics
Bone Marrow Cells
Guidelines

ASJC Scopus subject areas

  • Cancer Research
  • Genetics
  • Molecular Biology

Cite this

Standardization of fluorescence in situ hybridization studies on chronic lymphocytic leukemia (CLL) blood and marrow cells by the CLL Research Consortium. / Smoley, Stephanie A.; Van Dyke, Daniel L.; Kay, Neil E.; Heerema, Nyla A.; Dell' Aquila, Marie L.; Dal Cin, Paola; Koduru, Prasad; Aviram, Ayala; Rassenti, Laura; Byrd, John C.; Rai, Kanti R.; Brown, Jennifer R.; Greaves, Andrew W.; Eckel-Passow, Jeanette; Neuberg, Donna; Kipps, Thomas J.; Dewald, Gordon W.

In: Cancer Genetics and Cytogenetics, Vol. 203, No. 2, 12.2010, p. 141-148.

Research output: Contribution to journalArticle

Smoley, SA, Van Dyke, DL, Kay, NE, Heerema, NA, Dell' Aquila, ML, Dal Cin, P, Koduru, P, Aviram, A, Rassenti, L, Byrd, JC, Rai, KR, Brown, JR, Greaves, AW, Eckel-Passow, J, Neuberg, D, Kipps, TJ & Dewald, GW 2010, 'Standardization of fluorescence in situ hybridization studies on chronic lymphocytic leukemia (CLL) blood and marrow cells by the CLL Research Consortium', Cancer Genetics and Cytogenetics, vol. 203, no. 2, pp. 141-148. https://doi.org/10.1016/j.cancergencyto.2010.08.009
Smoley, Stephanie A. ; Van Dyke, Daniel L. ; Kay, Neil E. ; Heerema, Nyla A. ; Dell' Aquila, Marie L. ; Dal Cin, Paola ; Koduru, Prasad ; Aviram, Ayala ; Rassenti, Laura ; Byrd, John C. ; Rai, Kanti R. ; Brown, Jennifer R. ; Greaves, Andrew W. ; Eckel-Passow, Jeanette ; Neuberg, Donna ; Kipps, Thomas J. ; Dewald, Gordon W. / Standardization of fluorescence in situ hybridization studies on chronic lymphocytic leukemia (CLL) blood and marrow cells by the CLL Research Consortium. In: Cancer Genetics and Cytogenetics. 2010 ; Vol. 203, No. 2. pp. 141-148.
@article{653ce3965cb146438e5ba6159409a070,
title = "Standardization of fluorescence in situ hybridization studies on chronic lymphocytic leukemia (CLL) blood and marrow cells by the CLL Research Consortium",
abstract = "Five laboratories in the Chronic Lymphocytic Leukemia (CLL) Research Consortium (CRC) investigated standardizing and pooling of fluorescence in situ hybridization (FISH) results as a collaborative research project. This investigation used fixed bone marrow and blood cells available from previous conventional cytogenetic or FISH studies in two pilot studies, a one-day workshop, and proficiency test. Multiple FISH probe strategies were used to detect 6q-, 11q-, +12, 13q-, 17p-, and IGH rearrangements. Ten specimens were studied by participants who used their own probes (pilot study 1). Of 312 FISH interpretations, 224 (72{\%}) were true-negative, 74 (24{\%}) true-positive, 6 (2{\%}) false-negative, and 8 (3{\%}) false-positive. In pilot study no. 2, each participant studied two specimens using identical FISH probe sets to control for variation due to probe sets and probe strategies. Of 80 FISH interpretations, no false interpretations were identified. At a subsequent workshop, discussions produced agreement on scoring criteria. The proficiency test that followed produced no false-negative results and 4{\%} (3/68) false-positive interpretations. Interpretation disagreements among laboratories were primarily attributable to inadequate normal cutoffs, inconsistent scoring criteria, and the use of different FISH probe strategies. Collaborative organizations that use pooled FISH results may wish to impose more conservative empiric normal cutoff values or use an equivocal range between the normal cutoff and the abnormal reference range to eliminate false-positive interpretations. False-negative results will still occur, and would be expected in low-percentage positive cases; these would likely have less clinical significance than false positive results. Individual laboratories can help by closely following rigorous quality assurance guidelines to ensure accurate and consistent FISH studies in their clinical practice and research.",
author = "Smoley, {Stephanie A.} and {Van Dyke}, {Daniel L.} and Kay, {Neil E.} and Heerema, {Nyla A.} and {Dell' Aquila}, {Marie L.} and {Dal Cin}, Paola and Prasad Koduru and Ayala Aviram and Laura Rassenti and Byrd, {John C.} and Rai, {Kanti R.} and Brown, {Jennifer R.} and Greaves, {Andrew W.} and Jeanette Eckel-Passow and Donna Neuberg and Kipps, {Thomas J.} and Dewald, {Gordon W.}",
year = "2010",
month = "12",
doi = "10.1016/j.cancergencyto.2010.08.009",
language = "English (US)",
volume = "203",
pages = "141--148",
journal = "Cancer Genetics and Cytogenetics",
issn = "0165-4608",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - Standardization of fluorescence in situ hybridization studies on chronic lymphocytic leukemia (CLL) blood and marrow cells by the CLL Research Consortium

AU - Smoley, Stephanie A.

AU - Van Dyke, Daniel L.

AU - Kay, Neil E.

AU - Heerema, Nyla A.

AU - Dell' Aquila, Marie L.

AU - Dal Cin, Paola

AU - Koduru, Prasad

AU - Aviram, Ayala

AU - Rassenti, Laura

AU - Byrd, John C.

AU - Rai, Kanti R.

AU - Brown, Jennifer R.

AU - Greaves, Andrew W.

AU - Eckel-Passow, Jeanette

AU - Neuberg, Donna

AU - Kipps, Thomas J.

AU - Dewald, Gordon W.

PY - 2010/12

Y1 - 2010/12

N2 - Five laboratories in the Chronic Lymphocytic Leukemia (CLL) Research Consortium (CRC) investigated standardizing and pooling of fluorescence in situ hybridization (FISH) results as a collaborative research project. This investigation used fixed bone marrow and blood cells available from previous conventional cytogenetic or FISH studies in two pilot studies, a one-day workshop, and proficiency test. Multiple FISH probe strategies were used to detect 6q-, 11q-, +12, 13q-, 17p-, and IGH rearrangements. Ten specimens were studied by participants who used their own probes (pilot study 1). Of 312 FISH interpretations, 224 (72%) were true-negative, 74 (24%) true-positive, 6 (2%) false-negative, and 8 (3%) false-positive. In pilot study no. 2, each participant studied two specimens using identical FISH probe sets to control for variation due to probe sets and probe strategies. Of 80 FISH interpretations, no false interpretations were identified. At a subsequent workshop, discussions produced agreement on scoring criteria. The proficiency test that followed produced no false-negative results and 4% (3/68) false-positive interpretations. Interpretation disagreements among laboratories were primarily attributable to inadequate normal cutoffs, inconsistent scoring criteria, and the use of different FISH probe strategies. Collaborative organizations that use pooled FISH results may wish to impose more conservative empiric normal cutoff values or use an equivocal range between the normal cutoff and the abnormal reference range to eliminate false-positive interpretations. False-negative results will still occur, and would be expected in low-percentage positive cases; these would likely have less clinical significance than false positive results. Individual laboratories can help by closely following rigorous quality assurance guidelines to ensure accurate and consistent FISH studies in their clinical practice and research.

AB - Five laboratories in the Chronic Lymphocytic Leukemia (CLL) Research Consortium (CRC) investigated standardizing and pooling of fluorescence in situ hybridization (FISH) results as a collaborative research project. This investigation used fixed bone marrow and blood cells available from previous conventional cytogenetic or FISH studies in two pilot studies, a one-day workshop, and proficiency test. Multiple FISH probe strategies were used to detect 6q-, 11q-, +12, 13q-, 17p-, and IGH rearrangements. Ten specimens were studied by participants who used their own probes (pilot study 1). Of 312 FISH interpretations, 224 (72%) were true-negative, 74 (24%) true-positive, 6 (2%) false-negative, and 8 (3%) false-positive. In pilot study no. 2, each participant studied two specimens using identical FISH probe sets to control for variation due to probe sets and probe strategies. Of 80 FISH interpretations, no false interpretations were identified. At a subsequent workshop, discussions produced agreement on scoring criteria. The proficiency test that followed produced no false-negative results and 4% (3/68) false-positive interpretations. Interpretation disagreements among laboratories were primarily attributable to inadequate normal cutoffs, inconsistent scoring criteria, and the use of different FISH probe strategies. Collaborative organizations that use pooled FISH results may wish to impose more conservative empiric normal cutoff values or use an equivocal range between the normal cutoff and the abnormal reference range to eliminate false-positive interpretations. False-negative results will still occur, and would be expected in low-percentage positive cases; these would likely have less clinical significance than false positive results. Individual laboratories can help by closely following rigorous quality assurance guidelines to ensure accurate and consistent FISH studies in their clinical practice and research.

UR - http://www.scopus.com/inward/record.url?scp=78649999975&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78649999975&partnerID=8YFLogxK

U2 - 10.1016/j.cancergencyto.2010.08.009

DO - 10.1016/j.cancergencyto.2010.08.009

M3 - Article

C2 - 21156226

AN - SCOPUS:78649999975

VL - 203

SP - 141

EP - 148

JO - Cancer Genetics and Cytogenetics

JF - Cancer Genetics and Cytogenetics

SN - 0165-4608

IS - 2

ER -